Codexis (STU:4QK) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:4QK Codexis Inc STU:4QK
57 GF Score
Price €1.18
GF Value €2.22
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Codexis Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Codexis  (STU:4QK) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Codexis Cyclically Adjusted PB Ratio Related Terms


Codexis Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Codexis's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Codexis Cyclically Adjusted PB Ratio Chart

Codexis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.28 3.13 1.90 3.31 0.96

Codexis Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.43 1.50 1.00 0.99 1.40

STU:4QK vs SPRB, CRBU, MENS: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Codexis's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Codexis Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Codexis's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Codexis's Cyclically Adjusted PB Ratio falls into.


STU:4QK
57GF Score
Codexis Inc STU:4QK
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Codexis Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Codexis's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Codexis's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.315/333.9520*333.9520
=0.315

Current CPI (Jun. 2026) = 333.9520.

Codexis Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.493 241.428 0.682
201612 0.439 241.432 0.607
201703 0.261 243.801 0.358
201706 0.556 244.955 0.758
201709 0.387 246.819 0.524
201712 0.423 246.524 0.573
201803 0.250 249.554 0.335
201806 0.841 251.989 1.115
201809 0.874 252.439 1.156
201812 0.911 251.233 1.211
201903 0.836 254.202 1.098
201906 1.496 256.143 1.950
201909 1.610 256.759 2.094
201912 1.597 256.974 2.075
202003 1.530 258.115 1.980
202006 1.427 257.797 1.849
202009 1.307 260.280 1.677
202012 2.163 260.474 2.773
202103 2.160 264.877 2.723
202106 2.124 271.696 2.611
202109 2.250 274.310 2.739
202112 2.220 278.802 2.659
202203 2.183 287.504 2.536
202206 2.329 296.311 2.625
202209 2.398 296.808 2.698
202212 2.062 296.797 2.320
202303 1.739 301.836 1.924
202306 1.630 305.109 1.784
202309 1.238 307.789 1.343
202312 1.122 306.746 1.222
202403 1.040 312.332 1.112
202406 0.808 314.175 0.859
202409 0.808 315.301 0.856
202412 0.790 315.605 0.836
202503 0.555 319.799 0.580
202506 0.525 322.561 0.544
202509 0.363 324.800 0.373
202512 0.476 324.054 0.491
202603 0.413 330.213 0.418
202606 0.315 333.952 0.315

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Codexis (STU:4QK) Overvalued in 2026?

Based on GuruFocus' analysis, Codexis stock appears to be undervalued. The current stock price of €1.18 is trading 47% below its estimated GF Value™ of €2.22. GuruFocus considers Codexis to be Possible Value Trap.

Key valuation signals for STU:4QK:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €2.22 vs. price of €1.18 (47% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the STU:4QK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Codexis Business Description

Other Exchanges CDXS:USA0I0X:UK
Address 200 Penobscot Drive, Redwood City, CA, USA, 94063
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
57GF Score

Get the complete analysis for STU:4QK

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.18
Price
€2.22
GF Value